Home Search Abstracts View Session E-mail Abstract Author


Session 167-Poster Abstracts
Response to First-line ART in Children
Thursday, 2-4 pm; Poster Hall
Paper # 845    
IRIS-related Mortality in HIV-infected Children Admitted after Initiating ART in Uganda
Judy Orikiiriza*1, S Bakeera-Kitaka1, D Boulware2, Y Mulumba3, V Musiime4, P Mugyenyi4, and E Mworozi1
1Makerere Univ Coll of Hlth Sci, Kampala, Uganda; 2Univ of Minnesota, Minneapolis, US; 3Uganda-Case Western Reserve Univ Res Collaboration, Kampala; and 4Joint Clin Res Ctr, Kampala, Uganda

Background:  Mortality in resource-limited areas appears to be particularly high during the early months after antiretroviral therapy (ART) initiation. The causes for clinical deterioration after starting ART and the mortality attributable to Immune Reconstitution Inflammatory Syndrome (IRIS), however, have not been established. We investigated the IRIS-related mortality in HIV+ children in Uganda in the first 72 hours of admission.

Methods:  We conducted a prospective study of children aged ≤18 years at Joint Clinical Research Center receiving ART for 0.5 to 6 months duration during December 2006 to October 2007. We assessed clinical and laboratory data at time of ART initiation and study recruitment.  The children requiring hospitalization were followed for 72 hours, and acute mortality was assessed. Subjects were prospectively evaluated for IRIS by a standardized pediatric case definition. Data were analyzed using STATA version 10.

Results:  In this study, 162 children (1:1.3 male: female ratio) were evaluated with a median age of 6 years (Interquartile range: 2.5 to 11 years). The prevalence of IRIS was 38% (62/162, 95%CI: 31 to 46%) with (77%) unmasking and (23%) paradoxical IRIS events.  IRIS most frequently occurred in the first month of ART (55%). Overall, 24% (39/162) of subjects required hospitalization for IRIS which accounted for 62% (24/39) of all hospital admissions while on ART (OR = 3.6, 95%CI 1.7 to 7.6, =0.001). Mild IRIS events managed as an outpatient occurred in 24% (38/162). The overall survival was 94% (153/162). Of the 9 acute deaths, IRIS attributable mortality was 44% (n = 4). Mortality occurred in the first one month of ART (OR = 5.6, 95%CI 1.04 to 30.0, =0.07), and common characteristics of the children who died included severe immunosuppression, oral candidiasis, and malnutrition. 

Conclusions:  In resource-limited areas IRIS-related mortality is most likely to occur soon after ART initiation in children and adolescents with advanced immunosuppression and malnutrition. There is a need to start ART early to prevent morbidity and mortality after ART initiation in children. There is need for larger IRIS studies in children to assess the mortality burden in resource-limited areas.